CRIZOCENT 250 MG
Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including
CRIZONIX 250 MG
Crizonix Capsule 250 mg Indications Crizotinib is a kinase inhibitor indicated for the treatment of patients with- Metastatic non-small cell lung
ELOPAG 50 MG
Elopag Tablet Eltrombopag Olamine 50 mg Everest Pharmaceuticals Ltd. Also available as: 25 mg Indications Eltrombopag Olamine is indicated in Chronic
ELTROM 25 MG
DESCRIPTION ELTROM Eltrombopag 25MG Julphar Bangladesh Ltd. Composition: Eltrom Tablet: Each film coated tablet contains Eltrombopag Olamine INN equivalent to
HEPANIB 200 MG
Hepanib Tablet Sorafenib Tosylate 200 mg Everest Pharmaceuticals Ltd. Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with
LENVANIX 4 MG
Lenvanix (lenvatinib) 4 Mg Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor
LEVAT 10 MG
Levat Capsule Lenvatinib Mesylate 10 mg Julphar Bangladesh Ltd. Indications Lenvatinib is a kinase inhibitor that is indicated: For the treatment
LUCIBRU 140 MG
LUCIBRU Ibrutinib capsules 140mg 120 capsules Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton’s
LYNIB 100 MG
Lynib medicine 100mg Olaparib treats Ovarian cancer Brand name: Lynib Active ingredient: Olparib Content: 100mg Form: Capsules Package: 1 box of
NEXANIB 200 MG
Nexanib Tablet Sorafenib Tosylate 200 mg Julphar Bangladesh Ltd. Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with